Off the back of US approval of Leqembi, we have expert Dr Bill Brooks available to discuss Alzheimer's disease.
Dr Brooks has studied Alzheimer's Disease throughout his career and can comment on how the drug aims to work, what the evidence so far shows and also generally about Alzehimer's disease and its progression.
Nadia Razzhigaeva
Senior Communications & PR Officer
0452 140 477
As part of PDA’s 30th year celebrations, a new look was commissioned for both our logo and a refresh of our website to meet…
Researchers at Monash University and Flinders University have launched a series of microlearning education videos designed to support safer, more appropriate use of psychotropic medications for people living with dementia and in residential aged care. The video series includes 12 short, practical modules (approximately 5-7 minutes each) covering key topics including initiation, monitoring and discontinuation of antipsychotics, antidepressants and benzodiazepines. The videos are the latest in a suite of practical resources designed to support translation of key recommendations and good practice statements from the Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and…
Australian researchers haveunlockedthe possibility of creating smart wound dressingsthat enable real-time monitoring while also being able to deliver healingagentsin one simple, scalable platform. Chronic…
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.
